Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02230124 · ClinicalTrials.gov registry record · NA
Magnetic Resonance Elastography in Hydrocephalus
A NA study of Hydrocephalus, sponsored by Dartmouth-Hitchcock Medical Center.
- Active
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT02230124: Active NA study of Hydrocephalus, sponsored by Dartmouth-Hitchcock Medical Center.
NCT02230124 is a NA study of Hydrocephalus that is active but no longer recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 35 participants, below the 131-participant average among 17 other Hydrocephalus trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02230124, a NA study of Hydrocephalus, is active but no longer recruiting, sponsored by Dartmouth-Hitchcock Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to assess the utility of a new magnetic resonance technique called magnetic resonance elastography (MRE) in the non-invasive diagnosis of normal pressure hydrocephalus. The investigators hypothesize that MRE produces a unique imaging signature for hydrocephalus that distinguishes the disease from the normal (non-hydrocephalic) but atrophied brain, a distinction not possible with conventional MR imaging studies that are presently available.
Primary Outcome
The primary outcome measure will be mean shear modulus determined from pre-operative (and pre-drain placement) MRE in patients who demonstrate clinical improvement with trial CSF drainage versus patients who do not demonstrate improvement.
Conditions Studied
Interventions
- DEVICE MRE
Study Locations (1)
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2007-03-01 |
| Est. Completion | 2027-12-30 |
| Phase | NA |
What the registry record for NCT02230124 still lists
NCT02230124 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 131-participant average among 17 other Hydrocephalus trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Hydrocephalus appearing as the primary indexed condition, and to 1 intervention - of which MRE is the first listed.
NCT02230124 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT02230124 about?
NCT02230124 is a clinical study titled "Magnetic Resonance Elastography in Hydrocephalus". The purpose of this project is to assess the utility of a new magnetic resonance technique called magnetic resonance elastography (MRE) in the non-invasive diagnosis of normal pressure hydrocephalus. The investigators hypothesize that MRE produces a unique imaging signature for hydrocephalus that di...
What is the current status of trial NCT02230124?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2007-03-01. Estimated completion is 2027-12-30.
What conditions does trial NCT02230124 study?
This clinical trial studies the following conditions: Hydrocephalus.
What interventions are being tested in trial NCT02230124?
The interventions under investigation include: MRE (DEVICE).
Who is sponsoring clinical trial NCT02230124?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02230124 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hydrocephalus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02230124's enrollment target sits among peer trials
35 15th of 17 higher than 3 of 17 other Hydrocephalus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hydrocephalus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of CSF Shunt Flow and Headaches With a Thermal Measurement Device
RECRUITING · NA
-
EVD Drainage Data and Intracranial Pressure (ICP) Measurements
RECRUITING · NA
-
Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4
RECRUITING · NA
-
Flow Detection in Open and Closed Shunt Valve Periods
RECRUITING · NA
-
Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device
RECRUITING · NA
-
MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI